News & Press Releases Swedish

Scandinavian ChemoTech erhåller godkännande från europeiska patentverket

Scandinavian ChemoTech AB meddelar idag att Bolaget erhållit godkännande från det europeiska patentverket. Slutföreläggandet för denna patentansökan meddelades i ett pressmeddelande den 3 februari 2021. Granskaren kungör att godkännandet publiceras den 7 juli 2021.

Read more

Scandinavian ChemoTech ökar värdet på sin orderbok

Efter att Scandinavian ChemoTech AB (publ) idag mottagit en signerad elektronisk kopia av sitt CE-certifikat, ökar nu Bolaget sin orderbok med ytterligare ca 0,7 MSEK.

Read more

Styrelseledamot köper ytterligare aktier i Scandinavian ChemoTech AB

Scandinavian ChemoTech AB (publ) (“ChemoTech”) meddelar idag att Martin Jerndal, styrelseledamot, har köpt 3 980 aktier för cirka 112 000 SEK över börsen. Hans totala innehav uppgår nu till 582 695 aktier i ChemoTech.

Read more

News & Press Releases English

Scandinavian ChemoTech receives approval from the European Patent Office

Scandinavian ChemoTech AB announces today that the Company has received approval from the European Patent Office. The final injunction for this patent application was announced in a press release on the 3[d ]of February 2021. The examiner announces that the approval will be published 7[th] of July 2021.

Read more

Board member buys additional shares in Scandinavian ChemoTech AB

Scandinavian ChemoTech AB (publ) (“ChemoTech”) announces today that Martin Jerndal, board member, has bought 3,980 shares for approximately SEK 112,000 over the stock exchange. His total holding now amounts to 582,695 shares in ChemoTech.

Read more

Board members buys additional shares in Scandinavian ChemoTech AB

Scandinavian ChemoTech AB (publ) (“ChemoTech”) announces today that Bengt Engström, board member, has bought 5,000 shares for approximately SEK 162,500 over the stock exchange. His total holding now amounts to 43,000 shares in ChemoTech. Rolf Ehrnström, board member, has bought 10,000 shares for approximately SEK 326,000 over the stock exchange. His total holding now amounts…

Read more

ChemoTech Videos

ChemoTech presents at Småbolagsdagarna /Aktiespararna 9 June 2021. Spoken language is Swedish but the presentation is in English.

ChemoTech presents for its upcoming Annual General meeting 24 May 2021. Spoken language is Swedish but the presentation is in English.

ChemoTech answers questions from the shareholders; Part 1 (Swedish)

CEO Mohan Frick presenting at Erik Penser Bank Bolagsdag (Swedish)

Erik Penser Bank interview with CEO Mohan Frick (Swedish)

Company Presentation of the Q3 report (Swedish) 11th of November 2020

Company Presentation (Swedish) 27th of October 2020

Videos from 2019

Share Day in Gothenburg, November 4 2019 (Swedish)

Videos from 2018

Share analysis ChemoTech Q2 2018 (Swedish)

Share Day in Malmö on May 22, 2018 (Swedish)

Our foundation

Our profound knowledge in Electroporation forms the starting point for the company’s existing product and R&D projects : IQwave™ specially desinged for both TSE- Tumour Specific Electroporation and the first generation electrochemotherapy for the treatment of a range of different types of tumours.

Our research focus

Our aim is to document the effects of elctrochemotherapy for pain management for cancer patients, an area with significant unmet medical need.